CAS 59-05-2

Metotrexato

Descripción:

Metotrexato es un potente antimetabolito y agente inmunosupresor utilizado principalmente en el tratamiento de ciertos cánceres, enfermedades autoinmunes y embarazos ectópicos. Su fórmula química es C20H22N8O5S, y presenta una estructura de anillo de pteridina, que es crucial para su mecanismo de acción. Metotrexato funciona inhibiendo la enzima dihidrofólico reductasa, interrumpiendo así la síntesis de nucleótidos y afectando en última instancia la replicación del ADN y la división celular. Esto lo hace particularmente efectivo contra células de rápida división, como las que se encuentran en los tumores. Metotrexato se administra en varias formas, incluyendo tabletas orales y soluciones inyectables, y su farmacocinética puede variar según la vía de administración. El fármaco es conocido por sus posibles efectos secundarios, que pueden incluir trastornos gastrointestinales, toxicidad hepática y supresión de la médula ósea. Debido a sus propiedades inmunosupresoras, es esencial un monitoreo cuidadoso durante el tratamiento para gestionar los efectos adversos y las interacciones con otros medicamentos. El uso de Metotrexato en dosis más bajas para condiciones autoinmunes destaca su versatilidad en aplicaciones clínicas.

Fórmula: C₂₀H₂₂N₈O₅

InChI: InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1

Clave InChI: InChIKey=FBOZXECLQNJBKD-ZDUSSCGKSA-N

SMILES: NC=1C2=C(N=CC(CN(C)C3=CC=C(C(N[C@@H](CCC(O)=O)C(O)=O)=O)C=C3)=N2)N=C(N)N1

Sinónimos:

• (+)-4-Amino-10-Methylfolic Acid
• (+)-Amethopterin
• (2S)-2-[[4-[[(2,4-Diaminopteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic acid
• 4-Amino-1
• 4-Amino-4-Deoxy-N(Sup10
• 4-Amino-4-Deoxy-N(Sup10)Methylpteroylglutamic Acid
• 4-Amino-N 10-Methylpteroyl-L-Glutamic Acid
• 4-Amino-N10-methylfolic acid
• 4-Amino-N10-methylpteroylglutamic acid
• 4-Amino-N¹⁰-methylfolic acid
• 4-Amino-N¹⁰-methylpteroylglutamic acid
• <span class="text-smallcaps">L</span>-Amethopterin
• <span class="text-smallcaps">L</span>-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
• <span class="text-smallcaps">L</span>-Methotrexate
• Amethopterine
• Antifolan
• Caditrex
• Cl 14377
• Emt 25299
• Emtexate
• Emthexate PF
• Emtrexate
• Folex
• Folex PFS
• Folitrax
• Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, <span class="text-smallcaps">L</span>-(+)-
• Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, L-(+)-
• Jylamvo
• L-(+)-Amethopterin
• L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
• L-Methotrexate
• Ledertrexate
• Merex
• Metatrexan
• Methocel
• Methocip
• Methotrexat
• Methotrexat-Ebewe
• Methotrexate LPF
• Methoxtrexate
• Methylaminopterin
• Methylaminopterine
• Methylpteroylglutamate
• Methylpteroylglutamic Acid
• Metorex
• Metotrexato
• Mexate
• Mexate-AQ
• Mtx
• N-(P-(((2,4-Diamino-6-Pteridinyl)Methyl)Methylamino)Benzoyl)-L-Glutamic Acid
• N-[4-[[(2,4-Diamino-6-Pteridinyl)Methyl]Methylamino]Benzoyl]-L-Glutamic Acid
• N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-<span class="text-smallcaps">L</span>-glutamic acid
• N-[p-[[2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-<span class="text-smallcaps">L</span>-(+)-glutamic acid
• Nordimet
• Nsc 740
• Oncotrex
• R 9985
• Remtrex
• Rheumatrex
• Trexall
• Trilem

Methotrexate

CAS: 59-05-2

Methotrexate is used as s cell cycle arresting agent that inhibits DHFR. It is used in treatment of cancer, autoimmune diseases, ectopic pregnancy, and for the induction of medical abortions. It acts by inhibiting the metabolism of folic acid. Methotrexate is one of the most effective and widely use

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Yellow or yellow-orange, Powder or crystalline powder

Peso molecular: 454.45

Ref: 02-J63075

METHOTREXATE RS

CAS: 59-05-2

METHOTREXATE RS

Fórmula: C₂₀H₂₂N₈O₅

Peso molecular: 454.4393

Ref: 41-ICRS0345

METHOTREXATE CRS

CAS: 59-05-2

METHOTREXATE CRS

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Crystalline Powder. Yellow. Orange. Powder.

Peso molecular: 454.4393

Ref: 41-M1000000

METHOTREXATE FOR PEAK IDENTIFICATION CRS

CAS: 59-05-2

METHOTREXATE FOR PEAK IDENTIFICATION CRS

Fórmula: C₂₀H₂₂N₈O₅

Peso molecular: 454.4393

Ref: 41-Y0000602

Methotrexate

CAS: 59-05-2

Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Yellow Brown Orange Powder

Peso molecular: 454.17132

Ref: 45-1414003

Methotrexate

CAS: 59-05-2

Methotrexate (WR19039) is a folate analog, an inhibitor of the dihydrofolate reductase DHFR.

Fórmula: C₂₀H₂₂N₈O₅

Pureza: 96.84% - 99.91%

Forma y color: Orange-Brown Crystalline Powder Chemotherapy Drug That Interferes With Dna And Rna Synthesis

Peso molecular: 454.44

Ref: TM-T1485

Methotrexate

CAS: 59-05-2

Methotrexate

Fórmula: C₂₀H₂₂N₈O₅

Pureza: By hplc: 98.13% (Typical Value in Batch COA)

Forma y color: Yellow Solid-Powder

Peso molecular: 454.43927

Ref: 54-BIM0130

Methotrexate

CAS: 59-05-2

Methotrexate

Fórmula: C₂₀H₂₂N₈O₅

Pureza: ≥95%

Peso molecular: 454.44

Ref: 54-BUP17033

Methotrexate

CAS: 59-05-2

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Yellow Solid

Peso molecular: 454.45

Ref: 4Z-M-701

Methotrexate (Standard)

CAS: 59-05-2

Methotrexate (Standard) is a reference standard for research and analysis in studies involving Methotrexate. Methotrexate (WR19039) is a folate analog, an inhibitor of the dihydrofolate reductase DHFR. Methotrexate has antimetabolic, antitumor, and immunosuppressive activities, and is commonly used in rheumatoid arthritis and various tumors.

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Solid

Peso molecular: 454.44

Ref: TM-TMSM-3414

Methotrexate

Producto controlado

CAS: 59-05-2

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Neat

Peso molecular: 454.44

Ref: 04-C15056900

Methotrexate

Producto controlado

CAS: 59-05-2

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Neat

Peso molecular: 454.44

Ref: 86-MM0040.00

Methotrexate

CAS: 59-05-2

Forma y color: Neat

Ref: 61-FOR0040.00

Methotrexate Heptaglutamate Trifluoroacetate

CAS: 59-05-2

Fórmula: C₅₀H₆₄N₁₄O₂₃·C₂HF₃O₂

Peso molecular: 1229.14

Ref: 4Z-M-7026

Methotrexate

CAS: 59-05-2

(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid

Fórmula: C₂₀H₂₂N₈O₅

Pureza: 99% (contain ~10%water)

Peso molecular: 454.44

Ref: IN-DG43028

Methotrexate Heptaglutamate Trifluoroacetate

Producto controlado

CAS: 59-05-2

Fórmula: C₅₀H₆₄N₁₄O₂₃xC₂HF₃O₂

Forma y color: Neat

Peso molecular: 1229.12

Ref: TR-M260690

Methotrexate

CAS: 59-05-2

Stability Hygroscopic
Applications A Folic acid antagonist. Used as a antineoplastic and antirheumatic.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Freeman, M.V., J. Pharmacol. Exp. Ther., 122, 154 (1958), Weinblass, M.E., et al.: N. Engl. J. Med., 312, 818 (1985),

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Neat

Peso molecular: 454.44

Ref: TR-M260675

Methotrexate (1 mg/mL in Methanol with 0.1N NaOH)

CAS: 59-05-2

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Single Solution

Peso molecular: 454.44

Ref: TR-KIT0310

Methotrexate (1.0mg/mL in Methanol with 0.1N NaOH)

CAS: 59-05-2

Fórmula: C₂₀H₂₂N₈O₅

Ref: TR-KIT0310-1ML

Methotrexate

CAS: 59-05-2

Methotrexate is a chemotherapeutic and immunosuppressive medication, which is a synthetic analog of folic acid. Its source is through chemical synthesis, mimicking the structure of dihydrofolate in order to exert its effects. Methotrexate acts primarily by inhibiting the enzyme dihydrofolate reductase (DHFR), leading to a decrease in tetrahydrofolate production. This disruption in folate metabolism results in the inhibition of DNA, RNA, and protein synthesis, which affects rapidly dividing cells.Methotrexate is employed broadly in clinical oncology as an antineoplastic agent, particularly in the treatment of leukemias, lymphomas, breast cancer, and osteosarcoma. Additionally, it serves as a cornerstone for managing autoimmune diseases such as rheumatoid arthritis and psoriasis, where it helps modulate the aberrant immune response. The dual role of Methotrexate in oncology and immunosuppression underscores its versatility and critical importance in therapeutic regimens. However, its use demands careful monitoring due to potential adverse effects on non-cancerous cells and organ systems, necessitating precise dosage management and patient evaluation.

Fórmula: C₂₀H₂₂N₈O₅

Forma y color: Yellow Powder

Peso molecular: 454.44 g/mol

Ref: 3D-FA25165